Overview

A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects

Status:
NOT_YET_RECRUITING

Trial end date:
2025-03-19

Target enrollment:

Participant gender:

Summary

This is a single-center, open-label, fixed-sequence phase I clinical study to evaluate the effect of multiple subcutaneous injections of GZR18 Injection on the pharmacokinetics of multiple oral doses of metformin hydrochloride tablets.

Phase:

PHASE1

Details

Lead Sponsor:

Gan and Lee Pharmaceuticals, USA

Treatments:

Metformin